Form4insider filings, from the source

SEC Form 4/A · accession 0001209191-16-129285

Flexion Therapeutics Inc · FLXN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Period of report
Jun 10, 2016
Accepted (ET)
Jun 22, 2016 · 6:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001419600

Table I — non-derivative securities

No Table I lines on this filing.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F2$13.83Jun 10, 2016A12,500A—Jun 9, 2026Common Stock12,50012,500D

Explanation of responses